|
|
|
Issue Open Date
|
09-Nov-20
|
|
|
|
Issue Closing Date
|
11-Nov-20
|
|
|
|
Application Money
|
100
|
|
|
|
Allotment Money
|
|
|
|
|
|
|
|
Price Band
|
1490
-
1500
|
|
|
|
Minimium Application No.
|
10
|
|
|
|
Issue Size (Shares)
|
30237879
|
|
|
|
Market Lot
|
1
|
|
|
|
|
|
Objective
|
|
To finance the incremental working capital requirements of our CompanyTo meet funding requirements for capital expenditure requirementsTo meet the general corporate purposes
|
|
|
|
|
|
|
Category
|
No. of Shares
|
No. of Shares
|
Subscription Ratio
|
|
|
Offered / Reserved |
Bid For |
|
|
Non-Institutional Investors
|
6479546
|
3294470
|
0.508441486486862
|
|
Qualified Institutional Buyers
|
8639394
|
55250350
|
6.39516498495149
|
|
Retail Individual Investors
|
15118939
|
3610850
|
0.238829589827699
|
|
|
|
|
Business Description
|
|
|
Promoter's Holding
|
|
|
|
Total Share Capital
|
114662620
|
|
|
|
Offered to Public
|
43196968
|
|
|
|
Promoter's Holding (Pre-Issue)
|
74
|
|
|
|
Promoter's Holding (Post-Issue)
|
70.22
|
|
|
|
|
|
|
|
|
|
|
Address |
Survey No. 143-148
150 & 151
Near Gandimaisamma 'x' Roads
D. P. Pally
Dundigal Gandimaisamma Mandal
Medchal- Malkajgiri District
Hyderabad,
Telangana,
500043
Phone : 040 30510999
Email : gland@glandpharma.com / investor@glandpharma.com
Website : www.glandpharma.com
|
|
|
Registrar |
Link Intime India Pvt Ltd.
C 101
247 Park
LBS Marg
Vikhroli (West)
Mumbai
|
|
|
Listed at |
|
BSE, NSE
|
|
|
Lead Manager |
Citigroup Global Markets India Pvt Ltd.
Haitong Securities India Pvt Ltd.
Kotak Mahindra Capital Co Ltd
Nomura Financial Advisory & Securities (India) Pvt Ltd.
|
|
|
Promoters |
Fosun Pharma Industrial Pte. Ltd.
Shanghai Fosun Pharmaceutical (Group) Co. Ltd.
|
|
